This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany

Bernd Muehlenweg
SVP, Head of Global Business Development, Cell Therapy - Global BD iPSC Cell Therapy at Evotec
Speaker

Profile

More than 20 years in biotech have shown me the ups and downs of our industry. With many years in senior positions focusing on business & corporate development and alliance management every day is still part of an exciting journey.
Our industry is moving so fast, generates so many innovations that this is never a stand still. For me, this is a continuous learning embedded in experience! This will hopefully continue to enable me building sustainable, fruitful and durable alliances and partnerships to advance these innovations in approved medications.

Bernd Muehlenweg's Network

Agenda Sessions

  • Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices

    14:00